首页> 美国卫生研究院文献>other >Delayed febrile response with blood stream infections in patients with continuous flow left ventricular assist devices
【2h】

Delayed febrile response with blood stream infections in patients with continuous flow left ventricular assist devices

机译:连续流左心室辅助装置患者的发热反应延迟并伴有血流感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Blood stream infections (BSIs) are common in patients with continuous flow left-ventricular assist devices (CF-LVADs). Whether CF-LVADs modulate the febrile response to BSIs is unknown. We retrospectively compared the febrile response to BSIs in heart failure (HF) patients with CF-LVADs versus a control population of HF patients receiving inotropic infusions. BSIs were adjudicated using the Center of Disease Control and Prevention and the National Healthcare Safety Network criteria. Febrile status (temperature ≥100.4°F, 38°C), temperature at presentation with BSI, and highest temperature within 72 hours (Tmax) were collected. We observed 59 BSIs in LVAD patients and 45 BSIs in controls. LVAD patients were more likely to be afebrile and to have a lower temperature at presentation than control (88% vs. 58%, p=0.002 and 98.6±1.3 vs. 99.8±1.8, p=0.0009, respectively). By 72 hours, the difference in afebrile status diminished (53% vs. 44%, p=0.42), and the Tmax was similar between the LVAD and control groups (100.3°F±1.6 vs. 100.8°F±1.5, respectively, p=0.10). In conclusion, at presentation with a BSI, the vast majority of CF-LVAD patients were afebrile, an event which occurred at a higher frequency when compared to patients with advanced HF on chronic inotropes via an indwelling venous catheter. These data alert clinicians to have a very low threshold to obtain blood cultures in CF-LVAD patients even in the absence of fever. Further study is needed to determine whether a delayed or diminished febrile response represents another pathophysiological consequence of CF-LVADs.
机译:连续流左心室辅助装置(CF-LVAD)的患者常见血流感染(BSI)。 CF-LVADs是否调节对BSI的发热反应尚不清楚。我们回顾性地比较了CF-LVADs的心力衰竭(HF)患者与接受正性输注的HF患者的对照人群对BSI的发热反应。根据疾病控制与预防中心和国家医疗安全网络标准对BSI进行裁决。收集发热状态(温度≥100.4°F,38°C),BSI呈示时的温度以及72小时内的最高温度(Tmax)。我们在LVAD患者中观察到59个BSI,在对照组中观察到45个BSI。 LVAD患者较对照组更容易出现发热且体温较低(分别为88%vs. 58%,p = 0.002和98.6±1.3 vs. 99.8±1.8,p = 0.0009)。到72小时时,发热状态的差异减少了(53%对44%,p = 0.42),LVAD组和对照组的Tmax相似(分别为100.3°F±1.6 vs. 100.8°F±1.5, p = 0.10)。总之,在使用BSI时,绝大多数CF-LVAD患者是发热的,与通过内置静脉导管对慢性正性肌力药物治疗晚期HF的患者相比,该事件的发生频率更高。这些数据提醒临床医生,即使在没有发烧的情况下,CF-LVAD患者的血培养门槛也非常低。需要进一步的研究以确定延迟或减弱的发热反应是否代表CF-LVAD的另一种病理生理后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号